Affimed NV

NASDAQ: AFMD
$4.19
-$0.52 (-11.0%)
Closing price May 24, 2024

AFMD Chart and Intraday Price

AFMD Company Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address IM NEUENHEIMER FELD 582, 69120, HEIDELBERG, DE
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 97.07M USD
Shares Outstanding 14,933,900
Affimed NV, a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. The company is headquartered in Heidelberg, Germany.

AFMD Articles

Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.